Mesosil Analysis: $6M Raised
What is Mesosil?
Sustained release antimicrobial solutions for medical applications
Location
Toronto, Canada
Employees
1-10
Founded
2018
Product Features & Capabilities
- Mesosil® 500 platform for sustained release
- Antimicrobial additives for dental materials
- Customized solutions for medical devices
- Scalable synthesis of anti-infective materials
Use Cases
Reduce recurrent tooth decay by up to 80% in dental applications; Address biofouling in medical devices; Provide long-term antimicrobial protection in orthopedic implants; Collaborate on custom anti-infective solutions; Integrate into existing manufacturing workflows
Other Considerations
ISO13485:2016 certified for quality management; Focused on scalable synthesis of custom products; Expertise in anti-infective materials development
See something that needs updating? Suggest edits to this profile.